EU4Health

EU4Health
Name	EU4Health
Formation	2021
Type	Programme of the European Union
Headquarters	Brussels
Region	European Union
Budget	€5.3 billion (2021–2027)
Parent organization	European Commission

EU4Health is a financial initiative launched by the European Commission for the period 2021–2027 to strengthen health systems across the European Union. It aims to address cross-border health threats, increase preparedness for health emergencies, and support access to medicines and health workforce resilience. The programme complements other EU instruments such as Horizon Europe, Erasmus+, and the European Structural and Investment Funds while interacting with agencies like the European Centre for Disease Prevention and Control and the European Medicines Agency.

Background and objectives

EU4Health was developed in the aftermath of the COVID-19 pandemic and the 2020 joint response efforts led by the European Commission and the European Council. The initiative's objectives emphasize preparedness for public health emergencies, resilience of health systems in France, Germany, Italy, Spain, Poland, Netherlands, Belgium, Sweden, Romania, Greece, Portugal, Czech Republic, Hungary, Austria, and other member states. It supports joint procurement mechanisms related to Vaccination Campaigns, stockpiling linked to the Union Civil Protection Mechanism, and addresses challenges signalled by agencies including the World Health Organization and the Organisation for Economic Co-operation and Development. The programme's goals also respond to legal frameworks such as the Treaty on European Union and initiatives like the European Health Union.

Governance and funding

Governance of the programme involves the European Commission as the contracting authority, with strategic input from the European Parliament and the Council of the European Union. Financial oversight links to the European Court of Auditors and the European Anti-Fraud Office. Implementation is coordinated with executive agencies including the Executive Agency for Health and Consumers (historically), the European Health and Digital Executive Agency, and technical partners such as the European Centre for Disease Prevention and Control and the European Medicines Agency. Funding allocations were negotiated during the Next Generation EU recovery debates and the 2021–2027 Multiannual Financial Framework, resulting in a dedicated envelope to finance procurement, grants, and work programmes. Budgetary distributions also interact with national authorities of Lithuania, Latvia, Estonia, Slovakia, Slovenia, Croatia, Bulgaria, Cyprus, and Malta.

Programmes and activities

Core activities include strategic stockpiling, purchasing of medical countermeasures, support for clinical trials, and campaigns to strengthen vaccination uptake across Denmark, Finland, and Ireland. EU4Health finances preparedness exercises tied to the European Centre for Disease Prevention and Control frameworks and supports capacity-building projects in specialized institutions such as the Robert Koch Institute and the Institut Pasteur. It funds digitalisation efforts interoperable with the eHealth Digital Service Infrastructure and links to research calls under Horizon Europe for antimicrobials, rare diseases, and mental health. The programme supports workforce training initiatives analogous to those in Erasmus+ and fosters public health networks comparable to the European Reference Networks.

Implementation and partnerships

Implementation involves grant agreements with universities, hospitals, and non-governmental organizations in partnership with entities like the European Public Health Alliance, World Health Organization Regional Office for Europe, and Doctors Without Borders (MSF). The programme partners with industry stakeholders including pharmaceutical firms similar to GlaxoSmithKline, Pfizer, Roche, Novartis, Sanofi, and diagnostics companies aligned with procurement frameworks. Cooperation extends to international organisations such as the United Nations, the European Investment Bank, and bilateral arrangements with countries in the Western Balkans and the European Economic Area. Contracting and procurement follow EU rules under the Financial Regulation and procurement law adjudicated by bodies like the Court of Justice of the European Union.

Impact and evaluation

Assessments of EU4Health examine indicators such as stockpile readiness, health workforce numbers, vaccination coverage, and cross-border response times measured against benchmarks set by the European Centre for Disease Prevention and Control and the World Health Organization. Independent reviews reference methods used by the European Court of Auditors and evaluations commissioned by the European Commission. Early reports highlight investments in supplies for COVID-19 response, increased training for health professionals, and support for surveillance systems interoperable with the European Surveillance System (TESSy). Impact evaluations compare outcomes in countries like Germany, Italy, and Portugal and consider scalability in lower-capacity settings such as Bulgaria and Romania.

Criticisms and controversies

Critiques address the scale and targeting of funds, with commentators from think tanks such as Bruegel and Centre for European Reform questioning whether allocations sufficiently prioritized strengthening primary care versus procurement. Some member states and stakeholders raised concerns during negotiations at the European Council about conditionality, national implementation capacity, and overlap with Horizon Europe funding. Civil society organisations including European Public Health Alliance and academics from institutions like London School of Economics and Université Paris-Saclay have debated transparency, procurement processes, and industry engagement. Legal scholars referencing the Court of Justice of the European Union have analysed competence limits under the Treaty on the Functioning of the European Union concerning public health measures.

Category:European Union health policy